Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
61,148,715
-
Share change
-
+338,289
-
Total reported value
-
$445,772,118
-
Price per share
-
$7.29
-
Number of holders
-
108
-
Value change
-
-$528,079
-
Number of buys
-
67
-
Number of sells
-
41
Institutional Holders of POINT BIOPHARMA GLOBAL INC - COM (PNT) as of Q4 2022
As of 31 Dec 2022,
POINT BIOPHARMA GLOBAL INC - COM (PNT) was held by
108 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,148,715 shares.
The largest 10 holders included
BVF INC/IL, BlackRock Inc., PFM Health Sciences, LP, VANGUARD GROUP INC, STATE STREET CORP, CITADEL ADVISORS LLC, Point72 Asset Management, L.P., SUVRETTA CAPITAL MANAGEMENT, LLC, GREAT POINT PARTNERS LLC, and Boxer Capital, LLC.
This page lists
108
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.